NCT00193518View on ClinicalTrials.gov

Arsenic Trioxide in Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

PHASE2CompletedINTERVENTIONAL

Enrollment

41

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

April 30, 2006

Study Completion Date

April 30, 2006

Conditions

Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma

Interventions

DRUG

Arsenic Trioxide

Trial Locations (1)

37023

Tennessee Oncology, PLLC, Nashville

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

CTI BioPharma

INDUSTRY

lead

SCRI Development Innovations, LLC

OTHER